Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (101-110 of 607) with videos related to

Pageof 61
Sort By:
Annals of the Rheumatic Diseases|June 24, 2006
Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensionsC P Denton, M Humbert, L Rubin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2017
Review: Defining a Unified Vascular Phenotype in Systemic SclerosisYannick Allanore, Oliver Distler, Marco Matucci-Cerinic, et al.
Autoimmunity Reviews|August 4, 2015
The clinical relevance of sexual dysfunction in systemic sclerosisC Bruni, J Raja, C P Denton, et al.
Plos One|July 29, 2015
Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma SkinJoanna Nikitorowicz-Buniak, Christopher P Denton, David Abraham, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 20, 2016
ReplyVincent Sobanski, Jonathan Giovannelli, Christopher P Denton, et al.
Medical Hypotheses|June 3, 2018
Should all digital ulcers be included in future clinical trials of systemic sclerosis-related digital vasculopathy?Michael Hughes, Andrea Murray, Christopher P Denton, et al.
British Journal of Rheumatology|January 1, 1994
Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three casesC P Denton, P Sweny, A Abdulla, et al.
The Journal of Rheumatology|September 17, 2010
Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohortIvan Foeldvari, Svetlana I Nihtyanova, Angela Wierk, et al.
Autoimmunity Reviews|February 19, 2017
Towards developing criteria for scleroderma renal crisis: A scoping reviewSabrina Hoa, Edward P Stern, Christopher P Denton, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis-associated interstitial lung diseaseLutz Wollin, Jörg Hw Distler, Christopher P Denton, et al.
Pageof 61

Showing results (101-110 of 607) with videos related to

Sort By:
Pageof 61
Annals of the Rheumatic Diseases|June 24, 2006
Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensionsC P Denton, M Humbert, L Rubin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2017
Review: Defining a Unified Vascular Phenotype in Systemic SclerosisYannick Allanore, Oliver Distler, Marco Matucci-Cerinic, et al.
Autoimmunity Reviews|August 4, 2015
The clinical relevance of sexual dysfunction in systemic sclerosisC Bruni, J Raja, C P Denton, et al.
Plos One|July 29, 2015
Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma SkinJoanna Nikitorowicz-Buniak, Christopher P Denton, David Abraham, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 20, 2016
ReplyVincent Sobanski, Jonathan Giovannelli, Christopher P Denton, et al.
Medical Hypotheses|June 3, 2018
Should all digital ulcers be included in future clinical trials of systemic sclerosis-related digital vasculopathy?Michael Hughes, Andrea Murray, Christopher P Denton, et al.
British Journal of Rheumatology|January 1, 1994
Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three casesC P Denton, P Sweny, A Abdulla, et al.
The Journal of Rheumatology|September 17, 2010
Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohortIvan Foeldvari, Svetlana I Nihtyanova, Angela Wierk, et al.
Autoimmunity Reviews|February 19, 2017
Towards developing criteria for scleroderma renal crisis: A scoping reviewSabrina Hoa, Edward P Stern, Christopher P Denton, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis-associated interstitial lung diseaseLutz Wollin, Jörg Hw Distler, Christopher P Denton, et al.
Pageof 61